RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/36785788http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/36785788http://www.w3.org/2000/01/rdf-schema#comment"Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with high morbidity and mortality. Therefore, finding new diagnostic and therapeutic targets is vital for HCC patients. Recent studies have shown that dysregulation of RNA-binding proteins is often associated with cancer progression. Several studies have reported that the RNA-binding protein SSB can promote cancer occurrence and progression and is linked to tumor epithelial-mesenchymal transition (EMT), which could be a new diagnostic marker and therapeutic target. However, the expression and function of SSB in HCC remain to be elucidated. Therefore, this study is aimed at clarifying the expression and biological function of SSB in HCC through bioinformatics analysis combined with in vitro experiments. We found that SSB is highly expressed in HCC and is associated with the poor prognosis of HCC patients, and it can serve as an independent unfavorable prognostic factor. Knockdown of SSB can inhibit the growth of HCC cells in vitro, increase the level of apoptosis and the expression of pro-apoptosis-related proteins, and decrease the expression of antiapoptotic proteins. Meanwhile, SSB knockdown reduced HCC cell invasiveness, and the expression of EMT-related proteins changed significantly. We also found that the gene SSB was associated with the level of oxidative stress in liver cancer cells, and the level of intracellular reactive oxygen species (ROS) increased after knockdown of SSB. The results of bioinformatics analysis also showed that high expression of SSB may affect the effect of checkpoint blockade (ICB) therapy. In conclusion, we found that SSB is highly expressed in HCC and that upregulated SSB can promote the proliferation and metastasis of HCC through antiapoptotic, altered intracellular oxidative stress level, and EMT pathways, which can serve as a new diagnostic marker and therapeutic target, and patients with high SSB expression may not have obvious ICB therapy effect."xsd:string
http://purl.uniprot.org/citations/36785788http://purl.org/dc/terms/identifier"doi:10.1155/2023/5207431"xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/author"Bai Y."xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/author"Han P."xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/author"Han X."xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/author"Zhang Y."xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/author"Zhang Z."xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/author"Zhang J."xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/author"Wu H."xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/author"Zhang S."xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/author"Zhang Y.'"xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/date"2023"xsd:gYear
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/name"Oxid Med Cell Longev"xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/pages"5207431"xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/title"Upregulated SSB Is Involved in Hepatocellular Carcinoma Progression and Metastasis through the Epithelial-Mesenchymal Transition, Antiapoptosis, and Altered ROS Level Pathway."xsd:string
http://purl.uniprot.org/citations/36785788http://purl.uniprot.org/core/volume"2023"xsd:string
http://purl.uniprot.org/citations/36785788http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/36785788
http://purl.uniprot.org/citations/36785788http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/36785788
http://purl.uniprot.org/uniprot/#_B5BUB5-mappedCitation-36785788http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36785788
http://purl.uniprot.org/uniprot/#_Q14730-mappedCitation-36785788http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36785788
http://purl.uniprot.org/uniprot/#_Q2F832-mappedCitation-36785788http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36785788
http://purl.uniprot.org/uniprot/#_P05455-mappedCitation-36785788http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36785788
http://purl.uniprot.org/uniprot/#_Q9UMH5-mappedCitation-36785788http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36785788
http://purl.uniprot.org/uniprot/#_Q9UMH6-mappedCitation-36785788http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36785788